Compounded Semaglutide vs Wegovy: Understanding Your Weight Loss Options

By Matt Waterman · 2026-07-11

Wegovy and compounded semaglutide contain the same active pharmaceutical ingredient, semaglutide, which is a GLP-1 receptor agonist designed to mimic a naturally occurring hormone in the body. While Wegovy is the FDA-approved brand-name product manufactured by Novo Nordisk, compounded semaglutide is a customized medication prepared by a state-licensed compounding pharmacy during periods of drug shortages. Both versions are prescribed to patients meeting specific BMI eligibility requirements to aid in chronic weight management through enhanced appetite regulation and delayed gastric emptying.

What is the clinical difference between the two?

In terms of the core mechanism of action, there is no pharmacological difference between the semaglutide molecule found in Wegovy and the semaglutide found in high-quality compounded preparations. Both function as GLP-1 receptor agonists. These medications bind to GLP-1 receptors in the brain to signal satiety and in the gut to slow down digestion. This dual action helps patients adhere to a calorie-restricted diet by significantly reducing hunger signals and cravings. If you want the specifics, read wegovy vs zepbound.

The primary difference lies in the manufacturing and regulatory pathway. Wegovy is mass-produced in a standardized, FDA-approved facility and delivered in a proprietary single-use auto-injector pen. Compounded semaglutide is prepared by a pharmacist in a sterile environment, often provided in a multi-dose vial. For many patients, the choice between them comes down to accessibility during nationwide shortages. You can compare GLP-1 treatments to see how these options stack up against other medications like tirzepatide.

How does the cost and insurance coverage compare?

One of the most significant barriers to accessing brand-name Wegovy is the price. The list price for Wegovy can exceed 1300 dollars per month without insurance. Even for those with insurance, many plans specifically exclude weight loss medications from coverage, or they require a complex prior authorization process that can take weeks to resolve. This financial hurdle often prevents patients from starting their journey. We cover this in more detail in how much does wegovy cost without insurance.

Compounded semaglutide is typically offered at a significantly lower out-of-pocket price point. Because compounding pharmacies do not have the same marketing and proprietary device costs as big pharmaceutical companies, they can provide the medication for a fraction of the retail price. At HELiXVi, our GLP-1 program focuses on providing transparent pricing that often includes the cost of the virtual consultation and the medication delivered to your door, bypassing the need for insurance entirely.

Understanding BMI eligibility and medical requirements

Regardless of whether you choose a brand-name or compounded option, the medical criteria for a prescription remain the same. A licensed physician must evaluate your health history and current metrics. Standard BMI eligibility traditionally starts at a BMI of 30 or greater. However, patients with a BMI of 27 or greater may qualify if they also have at least one weight-related comorbidity, such as hypertension, type 2 diabetes, or high cholesterol.

During a consultation with a live AI video doctor, your provider will assess these factors to ensure semaglutide is safe for you. They will look for contraindications, such as a personal or family history of medullary thyroid carcinoma or Multiple Endocrine Neoplasia syndrome type 2. This screening is essential to ensure that your weight loss journey is managed medically and safely. For a deeper look, see our guide to semaglutide tablets weight loss timeline.

The titration schedule and managing side effects

Every semaglutide journey begins with an injection titration period. This means starting at a very low dose, typically 0.25 mg per week, and gradually increasing every four weeks. This slow ramp-up is designed to allow the body to acclimate to the gastric effects of the drug. Skipping steps in the titration process significantly increases the risk of acute gastrointestinal distress.

Common side effects for both Wegovy and compounded semaglutide include nausea, vomiting, diarrhea, and constipation. Most patients find that these symptoms are mild and subside as the body gets used to the medication. In some cases, a physician might adjust the titration schedule or suggest dietary modifications to mitigate discomfort. For more detailed information on managing these symptoms, see our related HELiXVi guide on GLP-1 side effects.

Feature	Wegovy (Brand Name)	Compounded Semaglutide
Active Ingredient	Semaglutide	Semaglutide
FDA Status	FDA-Approved Product	Compounded in Sterile Pharmacy
Delivery Method	Single-use Auto-injector	Vial and Insulin Syringes
Typical Monthly Cost	1300+ Dollars (without insurance)	250 to 500 Dollars
Insurance Requirement	Often requires Prior Auth	Usually Cash Pay / HSA

Is compounded semaglutide safe?

Safety in compounding depends entirely on the source. Compounding is a legal and regulated practice in the United States, especially when medicines are on the FDA drug shortage list. To ensure safety, it is vital to work with a licensed healthcare provider who uses PCAB-accredited or state-licensed compounding pharmacies that use high-purity pharmaceutical ingredients. These pharmacies must adhere to strict sterile processing standards known as USP 797.

Patients should be wary of websites selling substances labeled for research use only. These are not intended for human consumption and lack professional oversight. By choosing a reputable longevity program or weight loss clinic like HELiXVi, you ensure that your medication is sourced from legitimate, regulated pharmacies and that your progress is monitored by a US-licensed doctor.

The future of GLP-1: Oral options and new peptides

The field of metabolic medicine is moving quickly. While subcutaneous injections are currently the most common way to take semaglutide, there is also an oral GLP-1 option available for certain conditions. However, oral versions generally require significantly higher doses to achieve the same systemic absorption as an injection because much of the medication is broken down in the stomach. For weight loss specifically, the injectable form remains the gold standard for clinical efficacy. For a deeper look, see our guide to oral semaglutide weight loss reviews.

Research is also expanding into dual and triple-agonist peptides, such as tirzepatide, which targets both GLP-1 and GIP receptors. These newer medications may offer even greater weight loss potential for some patients. If you are struggling with thinning hair while losing weight, you might also be interested in our hair loss treatments, as rapid weight loss can sometimes trigger temporary thinning. To begin your clinical consultation for weight management, visit our GLP-1 intake portal today.

This article is educational and is not a substitute for individual medical advice. A HELiXVi physician determines what is appropriate for you.